Related Experiment Videos

[Improvement of hemorheology with ginkgo biloba extract. Decreasing a cardiovascular risk factor]

S Witte1, I Anadere, E Walitza

  • 1Medizinische Abteilung, Diakonissen-Krankenhaus Karlsruhe Rüppurr.

Fortschritte Der Medizin
|May 10, 1992
PubMed

Insights

This study found that ginkgo biloba extract (EGb 761) improved fibrinogen levels and hemorrheological properties in outpatients with cardiovascular risk factors. Long-term treatment positively influenced these key cardiovascular indicators.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Hemodynamics

Background:

  • Elevated fibrinogen levels and plasma viscosity are significant cardiovascular risk factors.
  • Common underlying conditions include coronary heart disease, hypertension, hypercholesterolemia, and diabetes mellitus.

Purpose of the Study:

  • To investigate the effect of ginkgo biloba extract (EGb 761) on fibrinogen levels and hemorrheological properties.
  • To assess the long-term influence of EGb 761 on cardiovascular risk factors.

Main Methods:

  • Open prospective study involving 20 outpatients.
  • Treatment administered: ginkgo biloba extract (EGb 761), 240 mg daily for 12 weeks.

Main Results:

  • Significant improvement observed in fibrinogen levels.
  • Demonstrated enhancement of hemorrheological properties.
  • EGb 761 positively influenced cardiovascular risk factors.

Conclusions:

  • Ginkgo biloba extract (EGb 761) is effective in improving fibrinogen levels and hemorrheological parameters.
  • Long-term treatment with EGb 761 shows potential in managing cardiovascular risk factors.
  • Further research into EGb 761 for cardiovascular health is warranted.
Abstract

Related Concept Videos